Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883266 · ClinicalTrials.gov registry record · NA

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

A NA study of Parkinsons Disease (PD), sponsored by Sanford Health.

Recruiting
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT06883266 is a NA study of Parkinsons Disease (PD) that is actively recruiting participants, run by Sanford Health. The registered enrollment target is 64 participants, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883266, a NA study of Parkinsons Disease (PD), is actively recruiting participants, sponsored by Sanford Health.

RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.

Conditions Studied

Interventions

  • DEVICE transcranial direct current stimulation (tDCS)
  • DEVICE Sham (No Treatment)

Study Locations (1)

North Dakota

  • Sanford Brain and Spine Center - Fargo

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2024-11-11
Est. Completion 2026-12-11
Phase NA

Sponsor

Sanford Health

34 total trials

What the Registry Record Tells You About NCT06883266

The ClinicalTrials.gov registry entry for NCT06883266 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (45% lower). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation (tDCS) is the first listed.

NCT06883266 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT06883266 about?

NCT06883266 is a clinical study titled "Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD". The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.

What is the current status of trial NCT06883266?

This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-11-11. Estimated completion is 2026-12-11.

What conditions does trial NCT06883266 study?

This clinical trial studies the following conditions: Parkinsons Disease (PD).

What interventions are being tested in trial NCT06883266?

The interventions under investigation include: transcranial direct current stimulation (tDCS) (DEVICE), Sham (No Treatment) (DEVICE).

Who is sponsoring clinical trial NCT06883266?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06883266 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinsons Disease (PD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.